Learning & Development Under the Microscope Volume 1 The Life-Sciences industry is constantly evolving under the pressure of new expectations. Regulators expect more transparency, consumers expect constant therapeutic advancement, while employees internal to these questions want more in return for the cost of shouldering that burden. It is a

Digital Therapeutics and Their Role in the Future of Modern Medicine Technology conveniences us at every turn. It empowers our behaviors and crystalises our understanding for the world through the tools we use to interact with it. We crutch our livelihoods on these systems, and depend on their advancement as our needs change, and our

Education as a strategy - Redefining emerging market access in pharmaceuticals “Impatience” is often cited as a major shortcoming among pharmaceutical companies trying their hand at emerging markets. The opportunity as discussed in theory, typically depicts the potential growth these countries have to offer, while the reality rarely presents itself so clearly. Emerging markets

Compliance modernization and the role of digital training initiatives Beyond first principles, compliance initiatives have rarely made the case for adding value within the commercial contexts they are applied. At least not in terms of how we traditionally define value creation. The standard for measuring and retracing this input poorly reflects the reality, and

Global Compliance Trends: Defining New Standards of Training Award winning compliance training programs look beyond tick the box requirements. The industry is laden with examples of “what not to do”, where learning solutions have fallen short, and business owners have felt the squeeze for mismanaging the needs of their employees. Failing to engage

How to Educate HCPs in the Digital World: 4 Strategic Considerations Through the other side of Covid has emerged a new pharmaceutical playground, unfamiliar to the once traditional frameworks and established channels of success. The context of relationships and business transactions stoked between physicians and pharma companies has transformed dramatically. Sales reps

Why Patient Education Creates Health Literacy There is no delicate means of addressing healthcare. Whether it is in terms of the price of our insurance coverage, the anxiety surrounding one’s next consultation, or the simple, transparent fear of being healthy today, but sick tomorrow. The difficulty is uncertainty. And although burying one’s head

Digital Therapeutics and the Role of Regulation: What’s in Store? Successful therapeutic development is dependent on a lot of things. Initially, it is as much an exercise in patience as it is capital. R&D is a costly and time-consuming enterprise, the kind that offers little reassurance in success, and given the associated cost,